SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-05-009926
Filing Date
2005-08-09
Accepted
2005-08-09 17:11:52
Documents
12
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a11405e10vq.htm 10-Q 184025
2 EXHIBIT 10.60 a11405exv10w60.txt EX-10.60 5272
3 EXHIBIT 10.61 a11405exv10w61.txt EX-10.61 5195
4 EXHIBIT 10.62 a11405exv10w62.txt EX-10.62 5192
5 EXHIBIT 10.63 a11405exv10w63.txt EX-10.63 5207
6 EXHIBIT 10.64 a11405exv10w64.txt EX-10.64 5179
7 EXHIBIT 10.65 a11405exv10w65.txt EX-10.65 5169
8 EXHIBIT 10.66 a11405exv10w66.txt EX-10.66 5169
9 EXHIBIT 10.67 a11405exv10w67.txt EX-10.67 5186
10 EXHIBIT 31.1 a11405exv31w1.txt EX-31.1 5375
11 EXHIBIT 31.2 a11405exv31w2.txt EX-31.2 5366
12 EXHIBIT 32.1 a11405exv32w1.txt EX-32.1 2109
  Complete submission text file 0000950137-05-009926.txt   239852
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 051010899
SIC: 2836 Biological Products, (No Diagnostic Substances)